Cargando…

Vildagliptin Improves Endothelium-Dependent Vasodilatation in Type 2 Diabetes

OBJECTIVE: To investigate whether the dipeptidyl peptidase-4 inhibitor vildagliptin improves endothelium-dependent vasodilatation in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: Sixteen subjects with type 2 diabetes (age 59.8 ± 6.8 years, BMI 29.1 ± 4.8 kg/m(2), HbA(1c) 6.97 ± 0.61) o...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Poppel, Pleun C.M., Netea, Mihai G., Smits, Paul, Tack, Cees J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161271/ https://www.ncbi.nlm.nih.gov/pubmed/21788633 http://dx.doi.org/10.2337/dc10-2421

Ejemplares similares

Inflammation in the subcutaneous adipose tissue does not attenuate endothelial function in subjects with diabetes mellitus and subjects with dyslipidaemia and hypertension: A cross‐sectional study
por: van Poppel, Pleun C. M., et al.
Publicado: (2018)

Inflammation and impaired endothelium-dependant vasodilatation in non obese women with gestational diabetes mellitus: preliminary results
por: Mrizak, Ines, et al.
Publicado: (2013)

Pirfenidone Is a Vasodilator: Involvement of K(V)7 Channels in the Effect on Endothelium-Dependent Vasodilatation in Type-2 Diabetic Mice
por: Beck, Lilliana, et al.
Publicado: (2021)

Activation of eNOS by D-pinitol Induces an Endothelium-Dependent Vasodilatation in Mouse Mesenteric Artery
por: Moreira, Luciana N., et al.
Publicado: (2018)

Hydrogen peroxide derived from NADPH oxidase 4- and 2 contributes to the endothelium-dependent vasodilatation of intrarenal arteries
por: Muñoz, Mercedes, et al.
Publicado: (2018)

Prolonged forearm ischemia attenuates endothelium-dependent vasodilatation and plasma nitric oxide metabolites in overweight middle-aged men
por: Aboo Bakkar, Zainie, et al.
Publicado: (2018)

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
por: Das, Sambit, et al.
Publicado: (2021)

Does vitamin C or its combination with vitamin E improve radial artery endothelium-dependent vasodilatation in patients awaiting coronary artery bypass surgery?
por: Uzun, Alper, et al.
Publicado: (2013)

Severe Hypouricemia Impairs Endothelium‐Dependent Vasodilatation and Reduces Blood Pressure in Healthy Young Men: A Randomized, Placebo‐Controlled, and Crossover Study
por: De Becker, Benjamin, et al.
Publicado: (2019)

Localized Vasodilatation
Publicado: (1933)

Diabetic Neuropathy and Axon Reflex-Mediated Neurogenic Vasodilatation in Type 1 Diabetes
por: Nabavi Nouri, Maryam, et al.
Publicado: (2012)

The Efficacy of Vildagliptin in Korean Patients with Type 2 Diabetes
por: Moon, Jun Sung, et al.
Publicado: (2013)

Reflex Vasodilatation in Surgery
por: Learmonth, J. R.
Publicado: (1943)

Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
por: Profit, Louise, et al.
Publicado: (2008)

Twelve-week randomized study to compare the effect of vildagliptin vs. glibenclamide both added-on to metformin on endothelium function in patients with type 2 diabetes and hypertension
por: Cosenso-Martin, Luciana Neves, et al.
Publicado: (2015)

A factorial randomized controlled trial to evaluate the effect of micronutrients supplementation and regular aerobic exercise on maternal endothelium-dependent vasodilatation and oxidative stress of the newborn
por: Ramírez-Vélez, Robinson, et al.
Publicado: (2011)

Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderly
por: Sicras-Mainar, Antoni, et al.
Publicado: (2014)

Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis
por: Kume, Shinji, et al.
Publicado: (2012)

Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in “Real-World” Management of Type 2 Diabetes Mellitus: The G-FORCE Study
por: Van Gaal, Luc, et al.
Publicado: (2019)

Antidromic vasodilatation and the migraine mechanism
por: Geppetti, Pierangelo, et al.
Publicado: (2011)

Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide
por: Kudo‐Fujimaki, Kyoko, et al.
Publicado: (2013)

The potential role of vildagliptin in the management and prevention of type 2 diabetes mellitus
por: Chakraborti, C.K.
Publicado: (2008)

Vildagliptin: a new oral treatment for type 2 diabetes mellitus
por: Mathieu, Chantal, et al.
Publicado: (2008)

Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability
por: Pan, CY, et al.
Publicado: (2013)

The Efficacy of Vildagliptin Concomitant With Insulin Therapy in Type 2 Diabetic Subjects
por: Ito, Daisuke, et al.
Publicado: (2015)

The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction
por: Trevisan, Roberto
Publicado: (2017)

Artemisinin Improves Acetylcholine-Induced Vasodilatation in Rats with Primary Hypertension
por: Liu, Xuanxuan, et al.
Publicado: (2021)

Salvia Miltiorrhiza Root Water-Extract (Danshen) Has No Beneficial Effect on Cardiovascular Risk Factors. A Randomized Double-Blind Cross-Over Trial
por: van Poppel, Pleun C. M., et al.
Publicado: (2015)

Lipid apheresis: oxidative stress, rheology, and vasodilatation
por: Mellwig, K.-P., et al.
Publicado: (2012)

Diabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive?
por: van Diepen, Janna A., et al.
Publicado: (2016)

Migraine pain: reflections against vasodilatation
por: Panconesi, Alessandro, et al.
Publicado: (2009)

Some Observations on Vasodilatation after Sympathectomy
por: Richards, R. L.
Publicado: (1953)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
por: Ved, Paresh, et al.
Publicado: (2012)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus
por: Ved, Paresh, et al.
Publicado: (2013)

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus’
por: Mundra, Vishal
Publicado: (2012)

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
por: Jeon, Hyun Jeong, et al.
Publicado: (2011)

Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus
por: Dejager, Sylvie, et al.
Publicado: (2012)

Long-term efficacy of vildagliptin in patients with type 2 diabetes undergoing hemodialysis
por: Mera, Jun-ichiro, et al.
Publicado: (2015)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

Surfing the Vildagliptin Tsunami
por: Balachandran, Karthik
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9aanu04v8n7nv10me121ra5bfu